Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ombelet, W.
Right arrow Articles by Kruger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ombelet, W.
Right arrow Articles by Kruger, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 12, 1458-1463, Copyright © 1997 by Oxford University Press


ARTICLES

Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology

W Ombelet, H Vandeput, G Van de Putte, A Cox, M Janssen, P Jacobs, E Bosmans, O Steeno and T Kruger
Genk Institute for Fertility Technology, Z.O.L. Campus St Jan, Belgium.

This retrospective study aimed to evaluate the prognostic value of the inseminating motile count (IMC) and sperm morphology (using strict criteria) on success rates after homologous intrauterine insemination (IUI) combined with clomiphene citrate (CC) stimulation. A total of 373 couples underwent 792 IUI cycles in a predominantly (87.4%) male subfertility group. The overall cycle fecundity (CF) and baby take-home rate (BTH) was 14.6 and 9.9% respectively. The cumulative CF and BTH (per couple) after three cycles were 30.6 and 21.1% respectively. Overall, sperm morphology and IMC were of no prognostic value using receiver operating characteristic (ROC) curve analysis, but after classifying the study population into different subgroups according to IMC, sperm morphology turned out to be a valuable prognostic parameter in subgroup 1, i.e. IMC <1 x 10(6). In this subgroup, no pregnancies were seen when the morphology score was <4% and the mean value of sperm morphology was significantly different in the pregnant (8.3%) versus non-pregnant group (5.0%; P <0.05). The cumulative CF and BTH after three IUI cycles were comparable for all couples with the exception of those cases in which the IMC was <1 x 10(6) with a morphology score of <4% normal forms. We recorded only two twin pregnancies (2.5%) and no moderate or severe ovarian hyperstimulation syndrome. We conclude that in a selected group of patients without CC resistance and normal ovarian response following CC stimulation [maximum of three follicles with a diameter of >16 mm at the time of administration of human chorionic gonadotrophin (HCG)], IUI combined with CC-HCG can be offered as a very safe and non-expensive first-line treatment, at least with an IMC of >1 x 10(6) spermatozoa. In cases with <1 x 10(6) spermatozoa, CC- IUI remains important as a first-choice therapy provided the morphology score is > or =4%.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
W. Ombelet, I. Cooke, S. Dyer, G. Serour, and P. Devroey
Infertility and the provision of infertility medical services in developing countries
Hum. Reprod. Update, November 1, 2008; 14(6): 605 - 621.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. Kucuk, E. Sozen, and B. Buluc
Intrauterine Insemination With Double Ejaculate Compared With Single Ejaculate in Male Factor Infertility: A Pilot Study
J Androl, July 1, 2008; 29(4): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
ESHRE MonogrHome page
W. Ombelet, R. Campo, E. Bosmans, and M. Nijs
Intrauterine insemination (IUI) as a first-line treatment in developing countries and methodological aspects that might influence IUI success
ESHRE Monogr, July 1, 2008; 2008(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Pennings and W. Ombelet
Coming soon to your clinic: patient-friendly ART
Hum. Reprod., August 1, 2007; 22(8): 2075 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. Ombelet, G. Martens, P. De Sutter, J. Gerris, E. Bosmans, G. Ruyssinck, P. Defoort, G. Molenberghs, and W. Gyselaers
Perinatal outcome of 12 021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study
Hum. Reprod., April 1, 2006; 21(4): 1025 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
W. Ombelet, P. De Sutter, J. Van der Elst, and G. Martens
Multiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project
Hum. Reprod. Update, January 1, 2005; 11(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. D.M. Nicopoullos, P. A. Almeida, J. W.A. Ramsay, and C. Gilling-Smith
The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing
Hum. Reprod., October 1, 2004; 19(10): 2289 - 2297.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Wainer, M. Albert, A. Dorion, M. Bailly, M. Bergere, R. Lombroso, M. Gombault, and J. Selva
Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination
Hum. Reprod., September 1, 2004; 19(9): 2060 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. Ombelet, M. Grieten, Ph. D. Neubourg, G. Verswijvel, L. Buekenhout, P. Hinoul, and E. de Jonge
Undescended ovary and unicornuate uterus: Simplified diagnosis by the use of clomiphene citrate ovarian stimulation and magnetic resonance imaging (MRI)
Hum. Reprod., April 1, 2003; 18(4): 858 - 862.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.H. Duran, M. Morshedi, S. Taylor, and S. Oehninger
Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study
Hum. Reprod., December 1, 2002; 17(12): 3122 - 3128.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Slama, F. Eustache, B. Ducot, T.K. Jensen, N. Jorgensen, A. Horte, S. Irvine, J. Suominen, A.G. Andersen, J. Auger, et al.
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities
Hum. Reprod., February 1, 2002; 17(2): 503 - 515.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.G. Andersen, S. Ziebe, N. Jorgensen, J.H. Petersen, N.E. Skakkebak, and A. N. Andersen
Time to pregnancy in relation to semen quality assessed by CASA before and after sperm separation
Hum. Reprod., January 1, 2002; 17(1): 173 - 177.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.S. Bhal, N.D. Pugh, L. Gregory, S. O'Brien, and R.W. Shaw
Perifollicular vascularity as a potential variable affecting outcome in stimulated intrauterine insemination treatment cycles: a study using transvaginal power Doppler
Hum. Reprod., August 1, 2001; 16(8): 1682 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Gunalp, C. Onculoglu, T. Gurgan, T. F. Kruger, and C. J. Lombard
A study of semen parameters with emphasis on sperm morphology in a fertile population: an attempt to develop clinical thresholds
Hum. Reprod., January 1, 2001; 16(1): 110 - 114.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Awonuga and J. Govindbhai
Is waiting for an endogenous luteinizing hormone surge and/or administration of human chorionic gonadotrophin of benefit in intrauterine insemination?
Hum. Reprod., July 1, 1999; 14(7): 1765 - 1770.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.